Your browser doesn't support javascript.
loading
Susceptibility of HLA-E*01:03 Allele Carriers to Develop Cytomegalovirus Replication After Living-Donor Kidney Transplantation.
Guberina, Hana; da Silva Nardi, Fabiola; Michita, Rafael Tomoya; Dolff, Sebastian; Bienholz, Anja; Heinemann, Falko M; Wilde, Benjamin; Trilling, Mirko; Horn, Peter A; Kribben, Andreas; Witzke, Oliver; Rebmann, Vera.
  • Guberina H; Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Germany.
  • da Silva Nardi F; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Germany.
  • Michita RT; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Germany.
  • Dolff S; Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Germany.
  • Bienholz A; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Germany.
  • Heinemann FM; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Germany.
  • Wilde B; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Germany.
  • Trilling M; Institute for Virology, University Hospital Essen, University Duisburg-Essen, Germany.
  • Horn PA; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Germany.
  • Kribben A; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Germany.
  • Witzke O; Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Germany.
  • Rebmann V; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Germany.
J Infect Dis ; 217(12): 1918-1922, 2018 05 25.
Article en En | MEDLINE | ID: mdl-29228302
ABSTRACT
Cytomegalovirus (CMV) causes serious complications among solid organ transplant recipients. We report the positive correlation between the presence of the HLA-E*0103 allele in living-donor kidney recipients and CMV reactivation during the first year after transplantation. Thus, HLA-E genotyping may help identify CMV replication-prone patients who require individualized patient-based CMV management.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Replicación Viral / Antígenos de Histocompatibilidad Clase I / Infecciones por Citomegalovirus / Citomegalovirus Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Replicación Viral / Antígenos de Histocompatibilidad Clase I / Infecciones por Citomegalovirus / Citomegalovirus Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article